Cargando…

Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes

BACKGROUND: DNA methylation-associated studies on biliary tract cancer (BTC), including cholangiocarcinoma (CCA) and gallbladder cancer (GBC), may improve the BTC classification scheme. We proposed to identify the shared methylation changes of BTCs and investigate their associations with genomic abe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Zhiquan, Ji, Jun, Xu, Yu, Zhu, Yan, Gao, Chunfang, Wang, Guoqiang, Li, Chengcheng, Zhang, Yuzi, Zhao, Jing, Wang, Chenyang, Wen, Xiaofang, Zhang, Zhou, Li, Bingsi, Zhang, Zhihong, Cai, Shangli, Li, Bin, Jiang, Xiaoqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822710/ https://www.ncbi.nlm.nih.gov/pubmed/35130881 http://dx.doi.org/10.1186/s12916-021-02197-w

Ejemplares similares

Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
por: Sui, Jinke, et al.
Publicado: (2021)

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study
por: Qiao, Guibin, et al.
Publicado: (2021)

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022)

Quantitative detections of TP53 gene mutations improve the diagnosis and prognostic prediction of biliary tract cancers using droplet digital PCR
por: Xiao, Xiao, et al.
Publicado: (2021)

Laparoscopic common bile duct exploration in patients with previous abdominal biliary tract operations
por: Li, Min, et al.
Publicado: (2020)

Updates in Biliary Tract Cancers
por: Li, Daneng, et al.
Publicado: (2022)

Toripalimab in advanced biliary tract cancer
por: Li, Wei, et al.
Publicado: (2022)

Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer
por: Chen, Kezhong, et al.
Publicado: (2023)

Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non-radical resection: A real-world study
por: Feng, Feiling, et al.
Publicado: (2020)

Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer
por: Sun, Danyang, et al.
Publicado: (2019)

Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study
por: Kang, Guannan, et al.
Publicado: (2019)

Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment
por: Shi, Xuebing, et al.
Publicado: (2022)

The changes of subtype markers between first and second primary breast cancers
por: Li, Chenyang, et al.
Publicado: (2023)

Co-occurring genomic alterations and immunotherapy efficacy in NSCLC
por: Zhang, Fan, et al.
Publicado: (2022)

Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report
por: Sun, Li, et al.
Publicado: (2020)

Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts
por: Ye, Fuqiang, et al.
Publicado: (2016)

Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan‐cancer analysis
por: Shen, Dong, et al.
Publicado: (2021)

Effect of midkine on gemcitabine resistance in biliary tract cancer
por: Lu, Yongliang, et al.
Publicado: (2018)

Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis
por: Xing, Puyuan, et al.
Publicado: (2019)

Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas
por: Zaccari, Piera, et al.
Publicado: (2019)

Mutational spectrum and precision oncology for biliary tract carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2021)

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer
por: Li, Teng, et al.
Publicado: (2021)

Characteristics and metabolic potential of biliary microbiota in patients with giant common bile duct stones
por: Dai, Chenguang, et al.
Publicado: (2023)

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes
por: Chen, Xiaofeng, et al.
Publicado: (2021)

A prognostic signature based on adenosine metabolism related genes for ovarian cancer
por: Liang, Weifeng, et al.
Publicado: (2022)

BILIARY TRACT DISORDERS
Publicado: (1984)

Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival
por: Ma, Ling, et al.
Publicado: (2018)

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers
por: Li, Yun-cheng, et al.
Publicado: (2022)

Anti-PD-1 Therapy plus Chemotherapy and/or Bevacizumab as Second Line or later Treatment for Patients with Advanced Non-Small Cell Lung Cancer
por: Zhang, Fan, et al.
Publicado: (2020)

Combination Therapies for Advanced Biliary Tract Cancer
por: Zeng, Weifeng, et al.
Publicado: (2023)

Diet–Cognition Associations Differ in Mild Cognitive Impairment Subtypes
por: Huang, Qiumin, et al.
Publicado: (2021)

Preoperative biliary drainage for biliary tract and ampullary carcinomas
por: Nagino, Masato, et al.
Publicado: (2008)

Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer
por: Ito, Zensho, et al.
Publicado: (2022)

Congenital absence of the common bile duct: A rare anomaly of extrahepatic biliary tract
por: Mittal, Tarun, et al.
Publicado: (2016)

Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets
por: Lau, David K., et al.
Publicado: (2019)

Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures
por: Mody, Kabir, et al.
Publicado: (2022)

Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy
por: Zhang, Fan, et al.
Publicado: (2020)

Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2021)

An Assessment of Combination of the Camrelizumab With Chemotherapy in Metastatic Biliary Tract Cancers
por: Yu, Yi, et al.
Publicado: (2021)

Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma
por: Luo, Biyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f0rnp0nncu7f28qtmku98unji5